The Vincent du Vigneaud Award
The Vincent du Vigneaud Awards recognize outstanding achievement in peptide research at mid-career. The du Vigneaud Awards are sponsored by Bachem, and are awarded to two deserving recipients at the biennial American Peptide Symposia.
| 2023 | Helma Wennemers | ETH Zurich |
| 2023 | Marcey Waters | University of North Carolina at Chapel Hill |
| 2021 | Alanna Schepartz | University of California, Berkeley |
| 2021 | Joel Schneider | Center for Cancer Research, National Cancer Institute |
| 2019 | Annette Beck-Sickinger | Leipzig University |
| 2019 | Hiroaki Suga | The University of Tokyo |
| 2017 | Ronald Raines | University of Wisconsin at Madison |
| 2017 | Wilfred van der Donk | University of Illinois at Urbana-Champaign |
| 2015 | Jean Chmielewski | Purdue University |
| 2015 | David Craik | University of Queensland |
| 2013 | Michael Chorev | Harvard Medical Scool |
| 2013 | Kit Sang Lam | University of California, Davis School of Medicine |
| 2011 | Fernando Albericio | University of Barcelona |
| 2011 | Morten Meldal | Carlsberg Laboratories, Copenhagen |
| 2010 | Philip Dawson | Scripps Research |
| 2010 | Reza Ghadiri | Scripps Research |
| 2008 | Jeffery W. Kelly | Scripps Research |
| 2008 | Thomas W. Muir | Rockefeller University |
| 2006 | Samuel H. Gellman | University of Wisconsin |
| 2006 | Barbara Imperiali | Massachusetts Institute of Technology |
| 2004 | Stephen B. H. Kent | University of Chicago |
| 2004 | Dieter Seebach | Swiss Federal Institute of Technology at Zurich |
| 2002 | Robert Hodges | University of Colorado, School of Medicine |
| 2002 | Horst Kessler | Technical University of München |
| 2000 | Charles M. Deber | University of Toronto |
| 2000 | Richard A. Houghten | Torrey Pines Institute for Molecular Studies |
| 1998 | Peter W. Schiller | Clinical Research Institute of Montreal |
| 1998 | James A. Wells | Genentech, Inc. |
| 1996 | Arthur M. Felix | Hoffmann-La Roche, Inc. |
| 1996 | Richard G. Hiskey | University of North Carolina at Chapel Hill |
| 1994 | George Barany | University of Minnesota at Minneapolis |
| 1994 | Garland R. Marshall | Washington University Medical School at St. Louis |
| 1992 | Isabella Lugoski Karle | Naval Research Laboratory |
| 1992 | Wylie W. Vale | The Salk Institute for Biological Studies |
| 1990 | Daniel H. Rich | University of Wisconsin at Madison |
| 1990 | Jean E. Rivier | The Salk Institute for Biological Studies |
| 1988 | William F. DeGrado | DuPont Central Research |
| 1988 | Tomi K. Sawyer | The Upjohn Company |
| 1986 | Roger M. Freidinger | Merck, Sharp & Dohme |
| 1986 | Michael Rosenblatt | Massachusetts General Hospital |
| 1986 | James P. Tam | The Rockefeller University |
| 1984 | Betty Sue Eipper | The Johns Hopkins University |
| 1984 | Lila M. Gierash | University of Delaware |
| 1984 | Richard E. Mains | The Johns Hopkins University |
Vincent du Vigneaud, May 18, 1901 – December 11, 1978, was an American biochemist. He won the 1955 Nobel Prize in Chemistry “for his work on biochemically important sulphur compounds, especially for the first synthesis of a polypeptide hormone,” a reference to his work on the cyclic peptide oxytocin.
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see